MSCs eye drops(Nanjing Drum Tower Hospital)(MSCs eye drops(Nanjing Drum Tower Hospital))

概要

基本信息

药物类型

间充质干细胞疗法

别名-

靶点-

作用方式-

作用机制

干细胞替代物

治疗领域-

在研适应症-

非在研适应症-

原研机构

南京鼓楼医院

在研机构

南京鼓楼医院

非在研机构-

权益机构-

最高研发阶段早期临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

4

项与 MSCs eye drops(Nanjing Drum Tower Hospital) 相关的临床试验

CTRI/2023/06/054213

/ RecruitingN/AIIT

Evaluation of Comparative efficacy of Triphlala Grita eye drops along with Shatavari Ksheerapaka versus shatavari Grita eye drops and Shatavari Ksheerapaka systemically in the management of post-menopausal dry eye- A Randomised Control Trial

开始日期2023-07-05

申办/合作机构-

NCT05784519

/ Not yet recruiting早期临床1期IIT

Clinical Study of Mesenchymal Stem Cell Eye Drops for Treating Dry Eye Disease

The goal of this non-randomized, prospective, open, one-arm clinical study is to learn about the clinical efficacy of stem cell eye drops in patients with dry eye disease (DED) who failed to respond to artificial tear sodium hyaluronate eye drops three times a day for two weeks.
The main question aims to answer are:
How effective are stem cell eye drops in patients with DED?
How safe are stem cell eye drops for patients with DED? Participants will be treated with mesenchymal stem cells (MSCs) eye drops, 5×10^5 /50μl in each eye, twice a day for two weeks and they will be followed up for three months after treatment.

开始日期2023-06-01

申办/合作机构

南京鼓楼医院

ChiCTR2300071953

/ Recruiting临床1期

Evaluation of the efficacy and safety of Golden Eye Drops for the treatment of dry eye - a multicenter, randomized, double-blind, placebo-controlled post-market clinical trial.

开始日期2023-06-01

申办/合作机构